All News #Library
Others
Nanoscope Names Hallen COO to Boost Global Readiness
01 Apr 2026 //
PR NEWSWIRE
Nanoscope Data Presentation at 2025 Retina Specialists Meeting
28 Jul 2025 //
PR NEWSWIRE
Ashish Patel, PhD, Joins Nanoscope as Senior VP of Sales
27 Mar 2025 //
PR NEWSWIRE
Nanoscope Therapeutics Appointed Samuel Barone, M.D., as Chief Medical Officer
21 Sep 2023 //
PR NEWSWIRE
Nanoscope Therapeutics to Present at the BIO International Convention
05 Jun 2023 //
PR NEWSWIRE
Nanoscope Appoints Industry Veteran Vicente Anido Jr. as a Strategic Advisor
20 Mar 2023 //
PR NEWSWIRE
Charles & Nanoscope Announce Multifaceted Gene Therapy Manufacturing Partnership
18 Oct 2022 //
BUSINESSWIRE
Nanoscope Therapeutics Receives Fast Track Designation by the FDA for MCO-010
10 Oct 2022 //
FIRSTWORLDPHARMA
Nanoscope Therapeutics to Present at Eyecelerator during the American Academy
26 Sep 2022 //
PRNEWSWIRE
Nanoscope concludes enrolment in Stargardt disease gene therapy trial
14 Sep 2022 //
CLINICALTRIALSARENA
Nanoscope Announces Completion of Enrollment in STARLIGHT Phase 2 of MCO-010
13 Sep 2022 //
PRNEWSWIRE
Nanoscope to Present at 3rd Annual Gene Therapy for Ophthalmic Disorders Meeting
08 Sep 2022 //
PRNEWSWIRE
Nanoscope Announces Presentations at the 22nd Euretina Congress
29 Aug 2022 //
PRNEWSWIRE
Nanoscope Therapeutics to Present at the Retina Forum 2022
26 Aug 2022 //
PRNEWSWIRE
Nanoscope Therapeutics Appoints Two Pharmaceutical Industry Veterans
25 May 2022 //
PRNEWSWIRE
Nanoscope`s Vision Restoring Optogenetic Gene Therapy to be Featured in ARVO
26 Apr 2022 //
PRNEWSWIRE
Nanoscope Tx Completes Enrollment of Phase 2b Trial in Blind Patients
07 Feb 2022 //
PRNEWSWIRE
Nanoscope Announces FDA Clearance of IND for MCO-010 Gene Therapy
25 Jan 2022 //
PRNEWSWIRE
Nanoscope Therapeutics co-Founder and President to Present at World Orphan
15 Nov 2021 //
PRNEWSWIRE
Nanoscope President to Present at Eyecelerator during the ACO
09 Nov 2021 //
BIOSPACE
Nanoscope President to Present at Company Showcase of the OIS Retina
05 Oct 2021 //
STARLOCAL MEDIA
Nanoscope Bags $1.5M PIIb SBIR Grant for Activatable Opsin Gene Therapy in AMD
14 Sep 2021 //
PRNEWSWIRE
Nanoscope Announces Positive Results from Optogenetic Gene Therapy
08 Sep 2021 //
PRNEWSWIRE
Nanoscope`s Patient Dosed in Phase 2b clinical trial of Optogenetic Gene therapy
19 Jul 2021 //
PR NEWSWIRE
Nanoscope`s Optogenetic Gene Therapy Restores Clinically Meaningful Vision
03 Jun 2021 //
BIOSPACE

Market Place
Sourcing Support